文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Eosinophils Beyond the Esophagus: A Review of Non-EoE Eosinophilic Gastrointestinal Diseases.

作者信息

Lam Angela Y, Gonsalves Nirmala

机构信息

Department of Gastroenterology and Hepatology, Kaiser Permanente San Francisco, San Francisco, California.

Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

出版信息

Gastroenterol Hepatol (N Y). 2025 Aug;21(8):511-519.


DOI:
PMID:40894984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397780/
Abstract

For eosinophilic esophagitis (EoE), the most well researched of the eosinophilic gastrointestinal diseases (EGIDs), there is a plethora of knowledge for its diagnosis and management; however, much less guidance is available for the non-EoE EGIDs. Efforts have been made to characterize the clinical features, epidemiology, diagnosis, and natural history of EGIDs, as the frequency of the non-EoE EGIDs has continued to rise. The diagnosis of the different non-EoE EGIDs, eosinophilic gastritis, enteritis, and colitis, can be challenging because of their rarity and heterogeneous presentations which can lead to delayed diagnosis and poor health-related quality of life in affected patients. Guidelines for histologic evaluation and diagnostic criteria for non-EoE EGID are actively being developed. Effective management of non-EoE EGIDs is possible with currently available assessments and therapies, with more treatments on the horizon, highlighting the need for improved understanding of non-EoE EGIDs. This article will review the diagnosis and management of the non-EoE EGIDs, focusing on the consensus nomenclature, nuances in diagnosis, and management options.

摘要

相似文献

[1]
Eosinophils Beyond the Esophagus: A Review of Non-EoE Eosinophilic Gastrointestinal Diseases.

Gastroenterol Hepatol (N Y). 2025-8

[2]
Segmental overlap is common in eosinophilic gastrointestinal diseases and impacts clinical presentation and treatment.

Dis Esophagus. 2025-1-7

[3]
Non-eosinophilic esophagitis eosinophilic gastrointestinal diseases are more prevalent than eosinophilic esophagitis in Korean children: from a multicenter study based on new diagnostic criteria and nomenclature.

Front Pediatr. 2025-8-14

[4]
Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis.

Clin Gastroenterol Hepatol. 2024-7

[5]
Eosinophilic gastrointestinal disorders and the role for the epithelium in pathogenesis and treatment.

Curr Opin Pediatr. 2024-12-1

[6]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[7]
Eosinophilic Gastritis and Enteritis Are Increased in Families With Eosinophilic Esophagitis.

Am J Gastroenterol. 2023-2-1

[8]
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale.

Gastro Hep Adv. 2025-1-25

[9]
Prevalence and Distribution of Gastric Endoscopy Findings in Non-eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases: Influence of Atrophic Gastritis.

Intern Med. 2025-4-15

[10]
[Clinical features and prognosis associated risk factors analysis of non-eosinophilic esophagitis eosinophilic gastrointestinal diseases in children].

Zhonghua Er Ke Za Zhi. 2025-9-2

本文引用的文献

[1]
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale.

Gastro Hep Adv. 2025-1-25

[2]
Gastrointestinal Tissue Eosinophil Quantification in Healthy Adult Volunteers.

Gastroenterology. 2025-7

[3]
The Natural History of Eosinophilic Gastrointestinal Diseases Is Influenced by Age of Onset and Location of Involvement.

Am J Gastroenterol. 2024-9-1

[4]
Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis.

J Allergy Clin Immunol Pract. 2024-6

[5]
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.

J Pediatr Gastroenterol Nutr. 2024-1

[6]
Natural Histories and Disease Complications in a Cohort of 151 Children With Gastric or Duodenal Eosinophilia.

Am J Gastroenterol. 2024-7-1

[7]
Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series.

Clin Transl Gastroenterol. 2024-1-1

[8]
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial.

J Allergy Clin Immunol. 2023-9

[9]
Dupilumab treatment of eosinophilic gastrointestinal disease in an adolescent.

Pediatr Allergy Immunol. 2023-6

[10]
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet Gastroenterol Hepatol. 2023-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索